FDA Finds Faulty INR Monitor Did Not Affect ROCKET AF Results FDA Finds Faulty INR Monitor Did Not Affect ROCKET AF Results

Effects on outcomes from patients in the warfarin group of ROCKET unintentionally receiving higher doses of warfarin due to a faulty INR device were ' modest, ' new analyses by the FDA conclude.Medscape Medical News

Source: Medscape Neurology and Neurosurgery Headlines - October 13, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news